These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38138299)

  • 1. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
    Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series.
    Karsenty C; Tubman VN; Liu CJ; Fasipe T; Wyatt KEK
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29695. PubMed ID: 35373913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Initiation of Sub-Anesthetic Ketamine Infusion in Adults with Vaso-Occlusive Crises Is Associated with Greater Reduction in Sickle Cell Pain Intensity: A Single Center's Experience.
    Kenney MO; Becerra B; Mallikarjunan A; Shah N; Smith WR
    Pain Med; 2022 Dec; 23(12):2042-2049. PubMed ID: 35708641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional anesthesia and sickle cell crisis in pediatric patients: An educational-focused review.
    Elhamrawy A; Veneziano G; Tobias JD
    Paediatr Anaesth; 2024 Mar; 34(3):195-203. PubMed ID: 37983941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis.
    Moody K; Abrahams B; Baker R; Santizo R; Manwani D; Carullo V; Eugenio D; Carroll A
    J Pain Symptom Manage; 2017 Jun; 53(6):1026-1034. PubMed ID: 28192225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease.
    Sheehy KA; Finkel JC; Darbari DS; Guerrera MF; Quezado ZM
    Pain Pract; 2015 Nov; 15(8):E90-7. PubMed ID: 26205912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study.
    Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
    J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 32685602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Models of Pain in Sickle Cell Disease.
    Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
    Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study.
    Kang HA; Barner JC; Richards KM; Bhor M; Paulose J; Kutlar A
    J Health Econ Outcomes Res; 2020; 7(1):94-101. PubMed ID: 36873574
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional anesthesia and analgesia in sickle cell pain episodes: A scoping review.
    Howie BA; Rajput K; Chow R
    Interv Pain Med; 2022 Sep; 1(3):100108. PubMed ID: 39238512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
    Coyne KS; Currie BM; Callaghan M; Wyrwich KW; Pease S; Baker CL; Arkin S; Pittman DD
    Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.